Evidence-based detox comes down to chelation for confirmed heavy metal poisoning, targeted binders, regular sweating and a diet that supports the liver's Phase II pathways. Juice cleanses, foot pads and liver flushes lack credible support.
Mold illness (CIRS) is usually treated with the Shoemaker Protocol: leave the water-damaged building, take a binder such as cholestyramine, then correct abnormal blood markers step by step, ending with VIP nasal spray. The evidence comes mainly from small studies by one research group.
Chelation therapy uses drugs such as EDTA, DMSA and deferoxamine to remove heavy metals, and it is FDA approved for lead poisoning, iron overload and Wilson's disease. The 2024 TACT2 trial found no heart benefit, so off-label use for heart disease, autism or detox is not supported.
Evidence-based detox means supporting the liver, kidneys and gut, and using chelation only for documented exposures like lead poisoning. Juice cleanses, foot pads and liver flushes have little or no evidence behind them.
Heavy metal toxicity is harm from lead, mercury, arsenic or cadmium building up in the body. Adults often have fatigue, headaches, brain fog, tingling and high blood pressure, while children show learning and behavior problems; matched blood or urine tests confirm it.
You left the moldy building, but you are still sick. Chronic Inflammatory Response Syndrome (CIRS) explains why mold illness persists long after exposure ends — and what research says about treatment.
EDTA chelation therapy binds lead and other metals so the kidneys can remove them, and it is FDA approved for lead poisoning. TACT found a modest heart benefit in 2013, but the 2024 TACT2 trial in patients with diabetes found none.
Heavy metal detox that is supported by evidence means medical chelation after blood or urine testing confirms a raised metal level. Foot baths, zeolite and detox drops do not remove metals from tissue.
Mold toxicity treatment follows a specific, evidence-based sequence, from binders like cholestyramine to MARCoNS treatment and a realistic 6 to 18 month recovery timeline.
DMSA chelation uses oral succimer (Chemet) to bind lead, mercury and arsenic for urinary excretion. It is FDA approved only for pediatric lead poisoning; adult use for chronic low-level exposure is off label.
Heavy metal testing measures lead, mercury, arsenic and cadmium in blood, urine or hair, and the right test depends on the metal. Whole blood is the standard for lead, urine is preferred for arsenic and inorganic mercury, and hair and provoked tests are far less reliable.